Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LESLIE: Lifestyle Intervention in Neoadjuvant Therapy for TNBC
NCT06831955Phase 2Recruiting
- Sponsor
- UZ Leuven
- Start
- Feb 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in triple-negative breast cancer (TNBC) (2 arms), sponsored by UZ Leuven. Primary endpoint: Pathological Complete Response. Started Feb 2026; status: recruiting.
02
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT06831955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06831955.